Despite the fact that animal studies have shown that the use of AT1 receptor inhibitors may protect against abdominal aortic aneurysms, the outcomes of clinical research has been unsatisfying and often remains inconsistent (Maekawa et al., 2017). Here, AGTR1 is linked to abdominal aortic aneurysm.